Benjamin F. Edwards & Company’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,004
Closed -$33K 1774
2021
Q4
$33K Sell
1,004
-1,540
-61% -$50.7K ﹤0.01% 1133
2021
Q3
$89K Buy
2,544
+289
+13% +$11.3K ﹤0.01% 884
2021
Q2
$94K Buy
2,255
+146
+7% +$5.84K ﹤0.01% 865
2021
Q1
$78K Buy
2,109
+389
+23% +$14.7K ﹤0.01% 896
2020
Q4
$71K Buy
1,720
+1,552
+924% +$64.7K ﹤0.01% 876
2020
Q3
$7K Buy
+168
New +$7.25K ﹤0.01% 1345

Other funds holding FMS

Benjamin F. Edwards & Company's FMS Position: Q1 2022 in Review

Benjamin F. Edwards & Company sold out of Fresenius Medical Care (FMS) in Q1 2022, closing a stake of 1,004 shares — an estimated $33K sold.

Benjamin F. Edwards & Company first reported a position in FMS in Q3 2020 and held it in 6 quarters. The position peaked at $94K in Q2 2021. 178 funds tracked by Wall St. Rank hold FMS as of Q1 2022.

  • Benjamin F. Edwards & Company reported no remaining Fresenius Medical Care position as of Q1 2022 after selling out during the quarter.
  • Benjamin F. Edwards & Company sold 1,004 Fresenius Medical Care shares in Q1 2022, an estimated $33K.
  • Benjamin F. Edwards & Company first reported a position in Fresenius Medical Care in Q3 2020 and held it in 6 quarters.
  • Benjamin F. Edwards & Company's Fresenius Medical Care position peaked at $94K in Q2 2021.
  • 178 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q1 2022.

Based on Benjamin F. Edwards & Company's 13F filing for Q1 2022, filed 4 May 2022.